Search

Ordopidine

ACR325 is a dopaminergic stabiliser, which has demonstrated promising results in disease models for motor functions and psychoses. … ACR325 is developed for the treatment of Parkinson’s disease and psychoses, including bipolar disorder, for which disease existing therapies have only limited effect and considerable adverse side effects

Emoxypine

Emoxypine is under investigation in clinical trial NCT06221826 (MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure).

Phloroglucinol

Phloroglucinol has been used in trials studying the diagnostic of Colonoscopy.

Clenoliximab

Clenoliximab is a chimeric monoclonal antibody from _Macaca irus_ against CD4 which acts as an immunomodulator. It has investigated for the treatment of rheumatoid arthritis.

Flutemetamol

Flutemetamol is under investigation in clinical trial NCT02353949 (Investigating the Clinical Consequences of Flutemetamol-PET-scanning).

Tipranavir

Tipranavir is a sulfonamide-containing dyhydropyrone and a nonpeptidic protease inhibitor that targets the HIV protease. Tipranavir and ritonavir are coadministered to treat HIV.

Acifluorfen

Acifluorfen is a protoporphyrinogen oxidase inhibitor.

FK352B

FK352B is a adenosine A1 antagonist that is developed for the treatment of dialysis-induced hypotension.

Chlorocresol

Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen